SMT201600147B - Metodi per migliorare l'espressione di proteine ricombinanti - Google Patents

Metodi per migliorare l'espressione di proteine ricombinanti

Info

Publication number
SMT201600147B
SMT201600147B SM201600147T SM201600147T SMT201600147B SM T201600147 B SMT201600147 B SM T201600147B SM 201600147 T SM201600147 T SM 201600147T SM 201600147 T SM201600147 T SM 201600147T SM T201600147 B SMT201600147 B SM T201600147B
Authority
SM
San Marino
Prior art keywords
expression
improve
methods
recombinant proteins
recombinant
Prior art date
Application number
SM201600147T
Other languages
English (en)
Inventor
Howard Robert Grahame Clarke
Original Assignee
Cmc Icos Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cmc Icos Biolog Inc filed Critical Cmc Icos Biolog Inc
Publication of SMT201600147B publication Critical patent/SMT201600147B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C12Y105/01003—Dihydrofolate reductase (1.5.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SM201600147T 2009-08-06 2016-05-27 Metodi per migliorare l'espressione di proteine ricombinanti SMT201600147B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23190609P 2009-08-06 2009-08-06
PCT/US2010/044693 WO2011017606A1 (en) 2009-08-06 2010-08-06 Methods for improving recombinant protein expression

Publications (1)

Publication Number Publication Date
SMT201600147B true SMT201600147B (it) 2016-07-01

Family

ID=43544683

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600147T SMT201600147B (it) 2009-08-06 2016-05-27 Metodi per migliorare l'espressione di proteine ricombinanti

Country Status (15)

Country Link
US (3) US9212367B2 (it)
EP (1) EP2462237B1 (it)
KR (1) KR101800904B1 (it)
CN (1) CN102648285A (it)
AU (1) AU2010279294B2 (it)
CA (1) CA2771410C (it)
DK (1) DK2462237T3 (it)
ES (1) ES2563073T3 (it)
HR (1) HRP20160162T1 (it)
HU (1) HUE028655T2 (it)
NZ (1) NZ598275A (it)
PL (1) PL2462237T3 (it)
SI (1) SI2462237T1 (it)
SM (1) SMT201600147B (it)
WO (1) WO2011017606A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK201070194A (en) * 2010-05-08 2011-11-09 Univ Koebenhavn A method of stabilizing mRNA
KR102365484B1 (ko) * 2013-03-12 2022-02-18 에이쥐씨 바이올로직스, 인크. 하이브리드 chef1 프로모터를 이용한 향상된 재조합 단백질 발현
KR101446054B1 (ko) * 2013-03-14 2014-10-01 전남대학교산학협력단 재조합 단백질의 과발현을 위한 번역속도 조절용 램프 태그 및 이용
CN107794275B (zh) * 2017-11-06 2020-04-21 河北省微生物研究所 一种产(+)γ-内酰胺酶的重组毕赤酵母及其构建方法和应用
EP3737767A1 (en) 2018-01-10 2020-11-18 AGC Biologics, Inc. Bidirectional chef1 vectors
KR20200082618A (ko) 2018-12-31 2020-07-08 주식회사 폴루스 인슐린 과발현용 램프 태그 및 이를 이용한 인슐린의 제조방법
CN111434693B (zh) * 2019-01-11 2022-03-08 江苏芝大生物科技有限公司 一种抗氧化融合蛋白及应用
CN109979539B (zh) * 2019-04-10 2020-10-02 电子科技大学 基因序列优化方法、装置及数据处理终端
CN112301047A (zh) * 2020-11-02 2021-02-02 江苏东玄基因科技有限公司 一种精确调控重组蛋白表达的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
DK0669986T3 (da) * 1992-11-13 2003-07-28 Idec Pharma Corp Fuldstændigt inaktiverede kozac-sekvenser til ekspression i pattedyr
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
DE60336736D1 (de) * 2002-07-16 2011-05-26 VGX Pharmaceuticals LLC Codon-optimierte synthetische plasmide
KR20050083691A (ko) * 2002-09-13 2005-08-26 더 유니버시티 오브 퀸스랜드 코돈 번역 효율에 기초한 유전자 발현 시스템
US7344886B2 (en) * 2002-11-29 2008-03-18 Boehringer Ingelheim Pharma Gmbh & Co., Kg Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product
CN1771324A (zh) * 2003-02-03 2006-05-10 日本免疫股份有限公司 动物细胞用高表达载体
EP3312272B1 (en) 2004-10-08 2019-08-28 The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services Modulation of replicative fitness by using less frequently used synonymous codons
SI1809750T1 (sl) * 2004-11-08 2012-08-31 Chromagenics Bv Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina
EP1819829A1 (en) 2004-12-08 2007-08-22 ICOS Corporation Recombinant method for making multimeric proteins
US7429480B2 (en) 2005-01-10 2008-09-30 National Taiwan University Promoter sequences from WSSV immediate early genes and their uses in recombinant DNA techniques
US20070298503A1 (en) * 2006-05-04 2007-12-27 Lathrop Richard H Analyzing traslational kinetics using graphical displays of translational kinetics values of codon pairs

Also Published As

Publication number Publication date
EP2462237A4 (en) 2013-07-03
AU2010279294B2 (en) 2014-12-04
HUE028655T2 (en) 2016-12-28
EP2462237A1 (en) 2012-06-13
KR20120041245A (ko) 2012-04-30
NZ598275A (en) 2014-11-28
KR101800904B1 (ko) 2017-12-20
PL2462237T3 (pl) 2016-06-30
AU2010279294A1 (en) 2012-03-15
CN102648285A (zh) 2012-08-22
DK2462237T3 (da) 2016-03-29
US20160076043A1 (en) 2016-03-17
WO2011017606A1 (en) 2011-02-10
US20120214203A1 (en) 2012-08-23
ES2563073T3 (es) 2016-03-10
CA2771410A1 (en) 2011-02-10
US10066231B2 (en) 2018-09-04
US9212367B2 (en) 2015-12-15
US20190225972A1 (en) 2019-07-25
CA2771410C (en) 2020-10-06
EP2462237B1 (en) 2015-12-23
HRP20160162T1 (hr) 2016-04-08
SI2462237T1 (sl) 2016-04-29

Similar Documents

Publication Publication Date Title
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
SMT201700529T1 (it) Metodi per un'aumentata produzione di proteine
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
CY2017021I1 (el) Υψηλης συναφειας ανθρωπινα αντισωματα προς pcsk9
EP2539707A4 (en) ARTIFICIAL MYCOLIC ACID MEMBRANES
EP2475675A4 (en) MODULATION OF THE EXPRESSION OF HUNTINGTIN
EP2714970A4 (en) Enzyme QUANTIFICATION
EP2732037A4 (en) GENES AND PROTEINS FOR ALKANOYL COA SYNTHESIS
RU2557654C3 (ru) Терапевтические агенты для снижения уровней паратиреоидного гормона
EP2467157A4 (en) MODIFICATION OF RECOMBINANT ADENOVIRES WITH IMMUNOGENOUS PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
EP2629788A4 (en) USE OF HUMAN SERUM ALBUMIN TO REDUCE THE ANTIGENICITY OF THERAPEUTIC PROTEINS
IT1397620B1 (it) Asta per occhiali ed occhiali comprendenti quest'asta
BR112012025270A2 (pt) "composição de cuidados pessoais"
EP2619333A4 (en) PARALLEL SEQUENCING WITH NATIVE EXTENSION
EP2358868A4 (en) HUMAN LYMPHOCYTIC CELL LYMPHOCYTES CULTURE SYSTEM IN VITRO
FR2944062B1 (fr) Injecteur d'ergols
EP2285824A4 (en) PREPARATION OF PROTEIN ISOLATES
EP2872155A4 (en) BIOMATERIALS FOR IMPROVED IMPLANT HOST INTEGRATION
EP2532652A4 (en) THERAPEUTIC AGENT AGAINST HEPATITIS C
IT1404145B1 (it) Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2421882A4 (en) ANGIOGENESIS INHIBITORS
IT1395539B1 (it) Piede d'appoggio
EP2597152A4 (en) GENETICALLY MANIPULATED STRESS WSJ-IA FOR THE PREPARATION OF ISOVALERYL SPIRAMYCIN I.
EP2692734A4 (en) Cell Adhesion
EP2432501A4 (en) SECRETION-RELATED BACTERIAL PROTEINS FOR NLRC4 STIMULATION